Article
Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation.
Oncogene - 5 Sept 2013
Peyre M, Stemmer-Rachamimov A, Clermont-Taranchon E, Quentin S, El-Taraya N, Walczak C, Volk A, Niwa-Kawakita M, Karboul N, Giovannini M, Kalamarides M
Abstract excerpt
Aggressive variants of meningiomas (WHO grade II and III) represent up to 30% of those tumors that are among the most common primary central nervous system tumors in adults. Currently, there is no effective treatment for grade-II and -III meningiomas, the main treatment remaining surgical excisio...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
